Philadelphia 76ers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 4.8 | 2.7 | 0.7 | 1.0 | 4.3 | 0.0 | 0.3 | 0.7 | 1.0 | 1.0 |
| 100.0% |
| 0.0 |
| 0.0 |
| 0.0% |
| 0.7 |
| 0.7 |
| 100.0% |
| Last 5 | 5 | 10.4 | 5.4 | 2.0 | 1.6 | 9.0 | 0.0 | 0.2 | 1.0 | 2.2 | 3.4 | 64.7% | 0.0 | 0.6 | 0.0% | 1.0 | 1.2 | 83.3% |
| Last 10 | 10 | 15.2 | 7.8 | 3.1 | 2.6 | 13.5 | 0.3 | 0.4 | 1.5 | 2.9 | 4.5 | 64.4% | 0.0 | 1.1 | 0.0% | 2.0 | 2.3 | 87.0% |
| Last 20 | 20 | 15.9 | 7.2 | 3.1 | 2.4 | 12.7 | 0.3 | 0.6 | 1.4 | 2.9 | 4.3 | 66.7% | 0.0 | 1.0 | 0.0% | 1.4 | 1.6 | 84.4% |
| Season | 53 | 16.3 | 6.5 | 3.3 | 2.5 | 12.3 | 0.3 | 0.4 | 1.2 | 2.4 | 4.1 | 58.7% | 0.2 | 0.9 | 20.0% | 1.1 | 1.5 | 77.9% |
low deflections per minute, low assist rate
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | PHI vs. MIL | W | 6.6 | 2 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -15.0 |
| 2026-04-04 | PHI vs. DET | L | 4.9 | 4 | 1 | 2 | 0 | 0 | 1 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | -4.0 |
| 2026-04-01 | PHI @ WAS | W | 3.0 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0.0 |
| 2026-03-25 | PHI vs. CHI | W | 15.3 | 4 | 2 | 1 | 0 | 0 | 0 | 2 | 7 | 28.6% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 7.0 |
| 2026-03-23 | PHI vs. OKC | L | 22.1 | 15 | 6 | 4 | 0 | 0 | 3 | 6 | 10 | 60.0% | 0 | 2 | 0.0% | 3 | 4 | 75.0% | -8.0 |
| 2026-03-21 | PHI @ UTA | W | 23.5 | 20 | 9 | 4 | 0 | 0 | 3 | 7 | 11 | 63.6% | 0 | 1 | 0.0% | 6 | 6 | 100.0% | 15.0 |
| 2026-03-19 | PHI @ SAC | W | 10.0 | 2 | 2 | 2 | 0 | 0 | 3 | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | -17.0 |
| 2026-03-17 | PHI @ DEN | L | 21.9 | 12 | 3 | 6 | 1 | 3 | 2 | 3 | 7 | 42.9% | 0 | 2 | 0.0% | 6 | 6 | 100.0% | -9.0 |
| 2026-03-15 | PHI vs. POR | W | 27.0 | 7 | 2 | 3 | 1 | 0 | 0 | 3 | 7 | 42.9% | 0 | 2 | 0.0% | 1 | 2 | 50.0% | -8.0 |
| 2026-03-14 | PHI vs. BKN | W | 17.8 | 10 | 5 | 3 | 1 | 0 | 2 | 5 | 9 | 55.6% | 0 | 2 | 0.0% | 0 | 1 | 0.0% | -2.0 |
| 2026-03-12 | PHI @ DET | L | 19.6 | 4 | 2 | 1 | 1 | 1 | 1 | 2 | 5 | 40.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -20.0 |
| 2026-03-10 | PHI vs. MEM | W | 15.4 | 11 | 4 | 2 | 0 | 2 | 2 | 4 | 5 | 80.0% | 0 | 0 | 0.0% | 3 | 4 | 75.0% | -4.0 |
| 2026-03-09 | PHI @ CLE | L | 20.1 | 6 | 5 | 2 | 1 | 1 | 4 | 3 | 8 | 37.5% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-03-07 | PHI @ ATL | L | 18.6 | 10 | 2 | 2 | 0 | 1 | 0 | 5 | 7 | 71.4% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2026-03-04 | PHI vs. UTA | W | 22.4 | 7 | 7 | 3 | 0 | 1 | 1 | 3 | 6 | 50.0% | 0 | 0 | 0.0% | 1 | 1 | 100.0% | 6.0 |
| 2026-03-03 | PHI vs. SAS | L | 25.6 | 9 | 2 | 3 | 2 | 0 | 4 | 3 | 9 | 33.3% | 0 | 4 | 0.0% | 3 | 4 | 75.0% | -1.0 |
| 2026-03-01 | PHI @ BOS | L | 14.7 | 4 | 0 | 1 | 0 | 0 | 0 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -13.0 |
| 2026-02-26 | PHI vs. MIA | W | 10.7 | 2 | 6 | 3 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 10.0 |
| 2026-02-24 | PHI @ IND | W | 15.1 | 12 | 4 | 2 | 0 | 2 | 0 | 6 | 7 | 85.7% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2026-02-22 | PHI @ MIN | W | 3.0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 6.0 |
| 2026-02-19 | PHI vs. ATL | L | 16.3 | 4 | 2 | 0 | 0 | 0 | 1 | 1 | 6 | 16.7% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | -9.0 |
| 2026-02-11 | PHI vs. NYK | L | 24.8 | 6 | 4 | 4 | 1 | 0 | 3 | 3 | 10 | 30.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -27.0 |
| 2026-02-09 | PHI @ POR | L | 24.6 | 12 | 2 | 3 | 0 | 0 | 0 | 5 | 7 | 71.4% | 0 | 1 | 0.0% | 2 | 3 | 66.7% | -19.0 |
| 2026-02-07 | PHI @ PHX | W | 26.6 | 6 | 7 | 2 | 0 | 2 | 4 | 2 | 4 | 50.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | -8.0 |
| 2026-02-05 | PHI @ LAL | L | 15.7 | 6 | 2 | 2 | 0 | 0 | 1 | 3 | 3 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2026-02-03 | PHI @ GSW | W | 26.8 | 16 | 8 | 3 | 0 | 2 | 2 | 7 | 13 | 53.8% | 1 | 2 | 50.0% | 1 | 2 | 50.0% | 10.0 |
| 2026-02-02 | PHI @ LAC | W | 11.1 | 3 | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 1 | 2 | 50.0% | 3.0 |
| 2026-01-31 | PHI vs. NOP | W | 16.8 | 5 | 6 | 4 | 0 | 0 | 0 | 2 | 5 | 40.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -2.0 |
| 2026-01-27 | PHI vs. MIL | W | 6.2 | 2 | 1 | 3 | 1 | 0 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 8.0 |
| 2026-01-26 | PHI @ CHA | L | 17.2 | 3 | 2 | 0 | 1 | 0 | 1 | 1 | 6 | 16.7% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -14.0 |
| 2026-01-24 | PHI vs. NYK | L | 9.7 | 2 | 1 | 0 | 0 | 0 | 1 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2026-01-22 | PHI vs. HOU | W | 11.0 | 4 | 3 | 3 | 0 | 1 | 0 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2026-01-20 | PHI vs. PHX | L | 5.6 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -10.0 |
| 2026-01-19 | PHI vs. IND | W | 12.2 | 2 | 1 | 0 | 0 | 1 | 1 | 1 | 4 | 25.0% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | -9.0 |
| 2026-01-16 | PHI vs. CLE | L | 10.2 | 4 | 2 | 2 | 0 | 0 | 1 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 5.0 |
| 2026-01-14 | PHI vs. CLE | L | 17.2 | 3 | 2 | 4 | 0 | 0 | 0 | 1 | 3 | 33.3% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-01-12 | PHI @ TOR | W | 1.4 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -2.0 |
| 2026-01-11 | PHI @ TOR | L | 2.2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-01-07 | PHI vs. WAS | W | 4.8 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 3.0 |
| 2025-11-25 | PHI vs. ORL | L | 10.7 | 8 | 1 | 1 | 0 | 0 | 2 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 4 | 4 | 100.0% | -5.0 |
| 2025-11-23 | PHI vs. MIA | L | 26.1 | 19 | 9 | 7 | 1 | 1 | 1 | 7 | 12 | 58.3% | 1 | 2 | 50.0% | 4 | 5 | 80.0% | 5.0 |
| 2025-11-20 | PHI @ MIL | W | 14.4 | 0 | 6 | 3 | 1 | 0 | 1 | 0 | 4 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -8.0 |
| 2025-11-19 | PHI vs. TOR | L | 21.5 | 9 | 3 | 2 | 0 | 0 | 3 | 3 | 5 | 60.0% | 1 | 2 | 50.0% | 2 | 2 | 100.0% | -9.0 |
| 2025-11-17 | PHI vs. LAC | W | 18.9 | 8 | 3 | 4 | 1 | 0 | 1 | 4 | 6 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 10.0 |
| 2025-11-14 | PHI @ DET | L | 14.3 | 5 | 1 | 1 | 0 | 0 | 1 | 2 | 5 | 40.0% | 0 | 1 | 0.0% | 1 | 2 | 50.0% | -15.0 |
| 2025-11-11 | PHI vs. BOS | W | 21.4 | 7 | 2 | 1 | 0 | 0 | 1 | 3 | 10 | 30.0% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | -7.0 |
| 2025-11-09 | PHI vs. DET | L | 24.8 | 7 | 3 | 2 | 1 | 0 | 2 | 3 | 8 | 37.5% | 0 | 1 | 0.0% | 1 | 2 | 50.0% | 2.0 |
| 2025-11-08 | PHI vs. TOR | W | 36.5 | 20 | 17 | 10 | 0 | 1 | 1 | 8 | 10 | 80.0% | 1 | 2 | 50.0% | 3 | 5 | 60.0% | 12.0 |
| 2025-11-05 | PHI @ CLE | L | 23.1 | 16 | 3 | 6 | 2 | 0 | 2 | 5 | 9 | 55.6% | 2 | 2 | 100.0% | 4 | 4 | 100.0% | 6.0 |
| 2025-11-04 | PHI @ CHI | L | 19.0 | 8 | 4 | 2 | 0 | 0 | 2 | 2 | 4 | 50.0% | 0 | 0 | 0.0% | 4 | 5 | 80.0% | 2.0 |
| 2025-11-02 | PHI @ BKN | W | 25.5 | 16 | 9 | 7 | 0 | 1 | 2 | 7 | 9 | 77.8% | 1 | 2 | 50.0% | 1 | 1 | 100.0% | 19.0 |
| 2025-10-31 | PHI vs. BOS | L | 11.2 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -7.0 |
| 2025-10-28 | PHI @ WAS | W | 18.3 | 2 | 4 | 3 | 0 | 0 | 1 | 1 | 3 | 33.3% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 7.0 |